Compared to traditional fee-per-prescription reimbursement, the subscription model offers an expedient way to balance the public health interest in attaining widespread and affordable access to certain medications, while assuring manufacturers generate sufficient revenues.
Louisiana’s Experiment Paying For Hepatitis C Drugs: Lessons For Other States, Other Treatments?
